EUROESPES, S.A. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.34 EUR | -.--% |
|
-.--% | -.--% |
| 2023 | Euroespes, S.A. Auditor Raises 'Going Concern' Doubt | CI |
| 2023 | Euroespes, S.A. Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
| Sales 2021 | 3.85M 4.13M 343M | Sales 2022 | 3.86M 4.13M 344M | Capitalization | 5.8M 6.21M 517M |
|---|---|---|---|---|---|
| Net income 2021 | - 0 0 | Net income 2022 | -1M -1.07M -89.11M | EV / Sales 2021 | 2.12 x |
| Net Debt 2021 | 2.08M 2.23M 186M | Net Debt 2022 | 3.46M 3.71M 308M | EV / Sales 2022 | 2.4 x |
| P/E ratio 2021 |
-32.9
x | P/E ratio 2022 |
-4.75
x | Employees | 39 |
| Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 30.85% |
More Fundamentals
* Assessed data
More news
More news
1 year
0.32
0.37
3 years
0.320.59
5 years
0.320.75
10 years
0.321.26
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 22/22/22 | |
| Corporate Secretary | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 62 | - | |
| Director/Board Member | - | - | |
| Director/Board Member | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/24/30 | 0.34 | -.--% | 0 |
| 29/24/29 | 0.34 | -.--% | 0 |
| 26/24/26 | 0.34 | -.--% | 0 |
| 25/24/25 | 0.34 | -.--% | 0 |
| 24/24/24 | 0.34 | -.--% | 0 |
Delayed Quote BME, April 30, 2024 at 07:30 pm IST
More quotes
Euroespes SA is a Spain-based company engaged in the healthcare sector. The Company operates a medical center, which focuses on the prevention, diagnosis and treatment of central nervous system disorders, such as Alzheimer and Parkinson, and other common diseases. The Companyâs medical offer includes personalized treatment plans, genomic medicine, epigenetics, neuropsychology, neuro-ophthalmology, digital diagnosis, diagnostic imaging, clinical analysis and nursing services, among others. In addition, it provides pharmacogenetics services and Human Identification Genetics card, which identifies user's deoxyribonucleic acid (DNA) profile. The Company operates through a number of subsidiaries, such as in Euroespes Biotecnologia SA, Distribuidora de Productos SL and Ebiotec Pharma SL.
| 1st Jan change | Capi. | |
|---|---|---|
| -.--% | 3.93M | |
| -28.69% | 85.35B | |
| +14.32% | 81.95B | |
| +9.37% | 28.99B | |
| -11.43% | 16.98B | |
| -0.36% | 16.85B | |
| -0.24% | 15.35B | |
| +4.32% | 12.42B | |
| +33.40% | 12.19B | |
| -31.40% | 11.89B |
- Stock Market
- Equities
- EEP Stock
